In vitro Antiproliferative Studies of Selected Medicinal Plants on Cancerous and Normal Cells
Regina W. Mbugua, Eliud M. Njagi, Chrispus M. Ngule, Peter G. Mwitari
European Journal of Medicinal Plants · pp. 1–10 · Published 25 Aug 2022
10.9734/ejmp/2022/v33i1030491Abstract
Globally, approximately 13% of all deaths annually are attributed to cancer. Surgery, radiation and chemotherapy are the current treatment techniques for cancer; however, these methods are expensive, have high failure rates and have been associated with detrimental side effects. Plant derived products could be good candidates in alleviating challenges being experienced with these current methods. This study aimed at evaluating the phytochemistry, antiproliferation potential, and probable mechanism of action of Albizia gummifera, Rhamnus staddo and Senna didymobotrya plant extracts. The 3– (4, 5-dimethylthiazol-2-yl) -2, 5-diphenyltetrazolium (MTT) assay dye was used in the determination of the antiproliferative activity of the extracts. Extracts induction potential of p53 (apoptosis) and VEGF (angiogenesis) genes’ expression was evaluated using Real Time PCR. Phytochemical screening was done as per standard procedures. Several plant extracts exhibited antiproliferative activity against the cancerous cell lines tested showing selective toxicity to cancer cells while sparing the normal cells (SI ≥ 3). An upregulation of p53 and down-regulation VEGF genes was observed. Phytochemical screening revealed presence of pharmacologically important phytochemicals in the plant’s extracts. The study findings suggest exploitation of these plant extracts as potential candidates for development of drugs for the management of breast and prostate cancer.
References (26)
- 1 Cancer statistics for the year 2020: An overview [DOI]
- 2 Unravelling mechanisms of p53-mediated tumour suppression [DOI]
- 3 Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead [DOI]
- 4 Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells.
- 5 Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 1 [DOI]
- 6 Cafestol and Kahweol: A Review on Their Bioactivities and Pharmacological Properties [DOI]
- 7 Green synthesis of zinc oxide nanoparticles using leaf extracts of Raphanus sativus var. Longipinnatus and evaluation of their anticancer property in A549 cell lines [DOI]
- 8 Analysis of Flavonoids in Rhamnus davurica and Its Antiproliferative Activities [DOI]
- 9 The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer [DOI]
- 10 Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II [DOI]
- 11 Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 2 [DOI]
- 12 Cytotoxic Properties of Some Medicinal Plant Extracts from Mazandaran, Iran [DOI]
- 13 Physico-chemical and preliminary phytochemical screening of Psoralea corylifolia
- 14 Anti-proliferation activity of terpenoids isolated from Euphorbia kansui in human cancer cells and their structure-activity relationship [DOI]
- 15 The role of angiogenesis in prostate and other urologic cancers: a review.
- 16 CATHARANTHUS ROSEUS: ORNAMENTAL PLANT IS NOW MEDICINAL BOUTIQUE [DOI]
- 17 Phytochemical Screening of Medicinal Plants of the Kakamega Country, Kenya Commonly Used against Cancer [DOI]
- 18 A new targeting approach for breast cancer gene therapy using the Heparanase promoter [DOI]
- 19 Evaluation of in vitro antibacterial activity in Senna didymobotrya roots methanolic-aqua extract and the selected fractions against selected pathogenic microorganisms
- 20 Evaluation of retinoblastoma (Rb) and protein-53 (p53) gene expression levels in breast cancer cell lines (MCF-7) induced with some selected cytotoxic plants [DOI]
- 21 Prospective Role of Indian Medicinal Plants in Inhibiting Vascular Endothelial Growth Factor (VEGF) mediated Pathological Angiogenesis [DOI]
- 22 International Journal of Molecular Sciences [DOI]
- 23 Research Journal of Pharmacy and Technology [DOI]
- 24 Journal of Drug Delivery and Therapeutics [DOI]
- 25 Iranian Red Crescent Medical Journal [DOI]
- 26 International Journal of Research -GRANTHAALAYAH [DOI]
Cited by 11
Jing-Xiang Lim, P. Yong, Siew Huah Lim · Frontiers in Molecular Biosciences · 2026
Jing-Xiang Lim, P. Yong, Siew Huah Lim · Life Science · 2025
Showing 2 of 11 known citations — external sources report more than can currently be individually listed.
Related research
- Does Pain Adversely Affect the Quality of Life in Hospitalized Cancer Patients? — shares topic coverage
- Complementary Medicine Intervention in Breast Cancer Patients with Pain — shares topic coverage
- Use of Performance Status Score for Cytotoxic Chemotherapy among Surgeons in a Tertiary Hospital, Southern Nigeria — shares topic coverage
- Breast Self Examination and Cancer Awareness among Female Staff in Federal Medical Center, Yenagoa, Bayelsa State (Knowledge and Practice) — shares topic coverage
- Assessment of Cancer Risk from Fluorscopic Bile Duct Examinations at Sanjiwani Hospital, Gianyar — shares topic coverage
Article metrics
Real usage data collected on this platform.
62
Page views
0
PDF downloads
40
Outbound clicks
11
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.